FDA Investigator James W Blakely
James W Blakely has inspections in 2 countries as of 25 Sep 2023. James W Blakely has collaborated with a combined 1043 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
63
Last Inspection Date:
25 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alissa C Rice,
Amanda K Willey,
Andre L Duhon,
Andrew Saunders,
Barbara D Wright,
Barbara S Manson,
Bonnie E Conley,
Bonnie E Pierson,
Caitlin L Almonrode,
Carolyn E Barney,
Charles N Dupont,
Cherie T Parker,
Claire M Minden,
Combs,
Cynthia L Medlin,
Dana M Klimavicz,
David J Leray,
Debra A Taylor,
Denise J Taylor,
Donna D Gallien, MPH,
Dupont,
Dyvette Arline,
Eddie J Rigsby,
Edward H Maticka,
Elizabeth D Connell,
Francis A Guidry,
George J Flynn,
Grant D Jones,
Herbert M Corbello,
Iris C Macinnes,
Jacquelyn Bradford,
Jamie P Webb,
Jason D Abel,
Javelle P Spann,
Juanelma H Palmer,
Kimberly A Dutzek,
Kip J Hanks,
Lakisha N Morton,
Llopis,
M Aabel I,
Marlene L Davis,
Marvin D Jones,
Matthew B Thomaston,
Michael T Nehring,
Michael W Roosevelt,
Natalie A Guidry,
Pamela M Thomas,
Samantha J Bradley,
Samuel L Collins,
Shannon Atlas,
Shelton L Stribling,
Shirhonda D Thorn,
Sidney M Smith,
State Agency,
Steven D Dittert,
Thomas B Smith,
Thomas O Morgan,
Tiana M Mckinley,
Traci M Armand,
Wanda B Coats,
Wayne S Fortenberry,
Wendy R Blame
James W Blakely's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2000 | EIR | McDaris, H. Lee, MD - EIR, 2000-04-19 |
April, 2000 | FDA 483 | H Lee McDaris, M D - Form 483, 2000-04-19 |
January, 2000 | EIR | Baxter Healthcare Corporation - EIR, 2000-01-12 |
January, 2008 | FDA 483 | Encore Medical Dba Chattanooga Group - Form 483, 2008-01-11 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more